{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"40.5","upperLimit":"53.2","value":"46.8"}]}],"title":"Patient Level CDR - Central Reader 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"38.9","upperLimit":"51.6","value":"45.2"}]}],"title":"Patient Level CDR - Central Reader 2"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"39.3","upperLimit":"52.0","value":"45.6"}]}],"title":"Patient Level CDR - Central Reader 3"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"34.6","upperLimit":"44.9","value":"39.7"}]}],"title":"Region-level PPV - Central Reader 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"49.6","upperLimit":"62.7","value":"56.2"}]}],"title":"Region-level PPV - Central Reader 2"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"40.7","upperLimit":"52.9","value":"46.8"}]}],"title":"Region-level PPV - Central Reader 3"}],"denoms":[{"counts":[{"groupId":"OG000","value":"250"}],"units":"Participants"}],"description":"Patient-level CDR was defined as the percentage of all patients scanned who had at least one TP lesion (localized correspondence between rhPSMA-7.3 (18F) PET imaging and the reference standard) regardless of any co-existing FP findings.\n\nRegion-Level PPV is defined as the regions which are true positive out of all regions with positive lesions.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients who received rhPSMA-7.3 (18F) injection followed by a PET/CT scan and for whom sufficient data are available to permit a clear classification following the SoT algorithm.","id":"OG000","title":"Efficacy Analysis Population (EAP)"}],"paramType":"NUMBER","populationDescription":"Patients who received rhPSMA-7.3 (18F) injection followed by a PET/CT scan and for whom sufficient data are available to permit a clear classification following the SoT algorithm.","reportingStatus":"POSTED","timeFrame":"Conventional images within 90 days of rhPSMA7.3 (18F) PET, followed by biopsy within 60 days post-PET scan or confirmatory imaging within 90 days post-PET scan","title":"Patient-level CDR and Region-level PPV of rhPSMA-7.3 (18F) PET in Patients Who Had Negative Baseline Conventional Imaging","type":"SECONDARY","unitOfMeasure":"percentage"}